Health Organization: World Malaria Report 2017. Geneva: World Health Organization, 2017. ,
Fighting drug-resistant Plasmodium falciparum: the challenge of artemisinin resistance, Clin Microbiol Infect, vol.19, issue.10, pp.908-916, 2013. ,
Spread of artemisinin resistance in Plasmodium falciparum malaria, N Engl J Med, vol.371, issue.5, pp.411-423, 2014. ,
Absence of putative artemisinin resistance mutations among Plasmodium falciparum in Sub-Saharan Africa: a molecular epidemiologic study, J Infect Dis, vol.211, issue.5, pp.680-688, 2015. ,
The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread, FEMS Microbiol Rev, vol.41, issue.1, pp.34-48, 2017. ,
, Methods for Surveillance of Antimalarial Drug Efficacy. Geneva: World Health Organization, 2009.
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria, Nature, vol.505, issue.7481, pp.50-55, 2014. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00921203
Artemisinin resistance in Plasmodium falciparum malaria, N Engl J Med, vol.361, issue.5, pp.455-467, 2009. ,
Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia, Clin Infect Dis, vol.51, issue.11, pp.82-89, 2010. ,
Emergence of artemisininresistant malaria on the western border of Thailand: a longitudinal study, Lancet, vol.379, issue.9830, pp.1960-1966, 2012. ,
K13-propeller polymorphisms in Plasmodium falciparum parasites from sub-Saharan Africa, J Infect Dis, vol.211, issue.8, pp.1352-1355, 2015. ,
Emergence of Mutations in the K13 Propeller Gene of Plasmodium falciparum Isolates from Dakar, Antimicrob Agents Chemother, vol.60, issue.1, pp.624-627, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01459954
A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms, N Engl J Med, vol.374, issue.25, pp.2453-2464, 2016. ,
Lack of artemisinin resistance in Plasmodium falciparum in northwest Benin after 10 years of use of artemisinin-based combination therapy, Parasite, vol.23, p.28, 2016. ,
Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator, Malar J, vol.10, p.339, 2011. ,
Parasite clearance after malaria therapy: staying a step ahead of drug resistance, BMC Med, vol.13, p.251, 2015. ,
Malaria parasite clearance, Malar J, vol.16, issue.1, p.88, 2017. ,
Open-label, randomized, noninferiority clinical trial of artesunate-amodiaquine versus artemether-lumefantrine fixed-dose combinations in children and adults with uncomplicated falciparum malaria in Côte d'Ivoire, Malar J, vol.13, p.439, 2014. ,
Efficacy and Safety of ArtesunateAmodiaquine versus Artemether-Lumefantrine in the Treatment of Uncomplicated Plasmodium falciparum Malaria in Sentinel Sites across Côte d'Ivoire, Malar Res Treat, vol.2015, issue.2, pp.1-8, 2015. ,
A Phase 3, Double-Blind, Randomized Study of Arterolane Maleate-Piperaquine Phosphate vs Artemether-Lumefantrine for Falciparum Malaria in Adolescent and Adult Patients in Asia and Africa, Clin Infect Dis, vol.62, issue.8, pp.964-971, 2016. ,
, World Wide Antimalarial Resistance Network. Parasite Clearance Estimator (PCE) WorldWide Antimalarial Resistance Network, 2015.
, Methods and Techniques for Clinical Trials on Antimalarial Drug Efficacy: Genotyping to Identify Parasite Populations, 2008.
Genotyping of Plasmodium falciparum. PCR-RFLP analysis, Methods Mol Med, vol.72, pp.117-129, 2002. ,
Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia, Malar J, vol.8, p.10, 2009. ,
Assessment of Efficacy and Safety of Arterolane Maleate-Piperaquine Phosphate Dispersible Tablets in Comparison With Artemether-Lumefantrine Dispersible Tablets in Pediatric Patients With Acute Uncomplicated Plasmodium falciparum Malaria: A Phase 3, Randomized, Multicenter Trial in India and Africa, Clin Infect Dis, vol.65, issue.10, pp.1711-1720, 2017. ,
, Infection and Drug Resistance, vol.97, issue.14, 2018.
Assessment of the efficacy of first-line antimalarial drugs after 5 years of deployment by the National Malaria Control Programme in Côte d'Ivoire, Open Access J Clin Trials, vol.3, pp.67-76, 2011. ,
In vivo parasitological measures of artemisinin susceptibility, J Infect Dis, vol.201, issue.4, pp.570-579, 2010. ,
Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data, BMC Med, vol.13, p.212, 2015. ,
Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria, Malar J, vol.13, p.32, 2014. ,
Early parasitological response following artemisinin-containing regimens: a critical review of the literature, Malar J, vol.12, p.125, 2013. ,
Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, Malar J, vol.13, pp.114-119, 1999. ,
Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study, Lancet Infect Dis, vol.12, issue.11, pp.851-858, 2012. ,
Assessing parasite clearance during uncomplicated Plasmodium falciparum infection treated with artesunate monotherapy in Suriname, Infect Drug Resist, vol.9, pp.261-267, 2016. ,
Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data metaanalysis, Malar J, vol.14, p.359, 2015. ,
No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali, Am J Trop Med Hyg, vol.87, issue.1, pp.23-28, 2012. ,
The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia, Malar J, vol.8, p.31, 2009. ,
Pharmacologic advances in the global control and treatment of malaria: combination therapy and resistance, Clin Pharmacol Ther, vol.82, issue.5, pp.601-605, 2007. ,
Plasmodium falciparum clearance is rapid and pitting independent in immune Malian children treated with artesunate for malaria, J Infect Dis, vol.211, issue.2, pp.290-297, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01989275
, Associations between IgG antibody responses to multiple Plasmodium falciparum antigens and treatment outcomes with ACTs in, vol.4, pp.234-243, 2017.
Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity, J Infect Dis, vol.207, issue.11, pp.1655-1663, 2013. ,
, Infection and Drug Resistance, vol.97, issue.14, 2018.